SCHEMBL5035162

SCHEMBL5035162

NC(=O)N(S)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.46
SERPINE1 P05121 2/20 0.42
EPHX1 P07099 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
TRPV1 Q8NER1 2/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 2/20 0.39
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
TPX2 Q9ULW0 1/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
PIM1 P11309 1/20 0.38
MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8386558 0.81 EPHX2 (0.47) EPHX2SERPINE1EPHX1SLC6A2SLC6A4
SCHEMBL13871456 0.79 EPHX2 (0.46) EPHX2SERPINE1EPHX1SLC6A2SLC6A4
SCHEMBL725811 0.79 MAPT (0.32) MAPT
SCHEMBL11580654 0.77 EPHX2 (0.44) EPHX2SERPINE1EPHX1SLC6A2SLC6A4
SCHEMBL21399423 0.77 EPHX2 (0.44) EPHX2SERPINE1EPHX1SLC6A2SLC6A4
SCHEMBL526027 0.77 CA1 (0.52) MAPTNOS3
SCHEMBL525760 0.77 CES2 (0.45) EPHX2KMT2A
SCHEMBL653551 0.74 PARP10 (0.55) KMT2A
SCHEMBL320721 0.74 KCNN4 (0.42) NOS3NOS1
SCHEMBL28980342 0.72 EPHX2 (0.46) EPHX2SERPINE1EPHX1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US disclosed
EP-1694673-B1 THIAZOLE DERIVATES HOFFMANN LA ROCHE (CH) 2008-01-16 EP disclosed
EP-1694673-A1 NOVEL THIAZOLE DERIVATES F.HOFFMANN-LA ROCHE AG (CH) 2006-08-30 EP disclosed
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed
WO-2005058887-A1 NOVEL THIAZOLE DERIVATES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 EPHX2 1229/4885SERPINE1 2354/4885EPHX1 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.